Pharmacodynamic approach to study the gene transfer process employing non-viral vectors

被引:8
作者
Aliño, SF [1 ]
Escrig, E [1 ]
Revert, F [1 ]
Guillem, VM [1 ]
Crespo, A [1 ]
机构
[1] Univ Valencia, Fac Med & Odontol, Dept Farmacol, Valencia 46010, Spain
关键词
gene transfer; non-viral vectors; potency; efficacy; dose-response; pharmacodynamic;
D O I
10.1016/S0006-2952(00)00503-7
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In the present work we set out to apply pharmacodynamic concepts derived from dose-response curves (Potency and Efficacy) to characterize the gene transfer efficiency of a vector:DNA complex. We employed two widely used vectors, the cationic lipid DOTAP (N,N,N-trimethyl 1-2-3-bis (1-oxo-9-octadecenyl)oxy (Z,Z)-1-propanaminium methyl sulfate) and the cationic polymer PEI (polyethylenimine, 800 kDa) to transfect several constructions of the green fluorescent protein cDNA. The analysis of dose-response curves indicated that in all cases the goodness-of-fit was > 0.99. Potency is a measure that provides information on gene activity per amount of DNA. Efficacy is a measure of maximum gene expression achievable using a specific vector:DNA complex, and depends on both the intrinsic efficacy of the gene (evaluated using different vectors to transfer the same gene construct) and on vector efficacy in DNA delivery (evaluated using a single vector to deliver different gene constructs). The results suggest that Potency and Efficacy are objective parameters for describing and comparing the goodness of vectors, as well as the intrinsic efficacy of a given gene construct. Furthermore, they are useful tools that may contribute to a better understanding of the mechanistic gene transfer process of each vector. BIOCHEM PHARMACOL 60;12:1845-1853, 2000. (C) 2000 Elsevier Science Inc.
引用
收藏
页码:1845 / 1853
页数:9
相关论文
共 26 条
[1]   GENE-THERAPY VECTORS AS DRUG-DELIVERY SYSTEMS [J].
AFIONE, SA ;
CONRAD, CK ;
FLOTTE, TR .
CLINICAL PHARMACOKINETICS, 1995, 28 (03) :181-189
[3]   GENE-TRANSFER WITH SYNTHETIC CATIONIC AMPHIPHILES - PROSPECTS FOR GENE-THERAPY [J].
BEHR, JP .
BIOCONJUGATE CHEMISTRY, 1994, 5 (05) :382-389
[4]   A VERSATILE VECTOR FOR GENE AND OLIGONUCLEOTIDE TRANSFER INTO CELLS IN CULTURE AND IN-VIVO - POLYETHYLENIMINE [J].
BOUSSIF, O ;
LEZOUALCH, F ;
ZANTA, MA ;
MERGNY, MD ;
SCHERMAN, D ;
DEMENEIX, B ;
BEHR, JP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (16) :7297-7301
[5]  
CRISTIANO RJ, 1995, J MOL MED-JMM, V73, P479
[6]   Nomenclature for synthetic gene delivery systems [J].
Felgner, PL ;
Barenholz, Y ;
Behr, JP ;
Cheng, SH ;
Cullis, P ;
Huang, L ;
Jessee, JA ;
Seymour, L ;
Szoka, F ;
Thierry, AR ;
Wagner, E ;
Wu, G .
HUMAN GENE THERAPY, 1997, 8 (05) :511-512
[7]   LOW-DENSITY-LIPOPROTEIN AS A VEHICLE FOR TARGETING ANTITUMOR COMPOUNDS TO CANCER-CELLS [J].
FIRESTONE, RA .
BIOCONJUGATE CHEMISTRY, 1994, 5 (02) :105-113
[8]  
GAO X, 1995, GENE THER, V2, P712
[9]   EFFICIENT GENE-TRANSFER INTO HUMAN HEPATOCYTES BY BACULOVIRUS VECTORS [J].
HOFMANN, C ;
SANDIG, V ;
JENNINGS, G ;
RUDOLPH, M ;
SCHLAG, P ;
STRAUSS, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (22) :10099-10103
[10]   DNA COMPLEXES WITH POLYCATIONS FOR THE DELIVERY OF GENETIC MATERIAL INTO CELLS [J].
KABANOV, AV ;
KABANOV, VA .
BIOCONJUGATE CHEMISTRY, 1995, 6 (01) :7-20